CSIMarket


Akebia Therapeutics Inc   (AKBA)
Other Ticker:  
 

Akebia Therapeutics Inc

AKBA's Fundamental analysis








Akebia Therapeutics Inc 's sales fell by -18.74 % in I. Quarter 2024 from the same quarter a year ago. Ranking at No. 1875

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -0.32 %

Akebia Therapeutics Inc net loss deacreased by in I. Quarter 2024 year on year, Akebia Therapeutics Inc net loss increased by -31.4 % in I. Quarter 2024 year on year,

More on AKBA's Growth


Akebia Therapeutics Inc
realized net loss in trailing twelve months.

Akebia Therapeutics Inc realized cash outflow of $ -0.08per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 1.19.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.32.


More on AKBA's Valuation
 
 Total Debt (Millions $) 30
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 487,247
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 6.92
 Tangible Book Value (Per Share $) -0.55

Akebia Therapeutics Inc
realized net loss in trailing twelve months.

Akebia Therapeutics Inc realized cash outflow of $ -0.08per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 1.19.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.32.


More on AKBA's Valuation

  Market Capitalization (Millions $) 223
  Shares Outstanding (Millions) 205
  Employees 384
  Revenues (TTM) (Millions $) 187
  Net Income (TTM) (Millions $) -44
  Cash Flow (TTM) (Millions $) -16
  Capital Exp. (TTM) (Millions $) -
  Total Debt (Millions $) 30
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 487,247
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) 6.92
  Tangible Book Value (Per Share $) -0.55

  Market Capitalization (Millions $) 223
  Shares Outstanding (Millions) 205
  Employees 384
  Revenues (TTM) (Millions $) 187
  Net Income (TTM) (Millions $) -44
  Cash Flow (TTM) (Millions $) -16
  Capital Exp. (TTM) (Millions $) -





  Ratio
   Capital Ratio (MRQ) 1.72
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) 0.78
  Inventory Turnover Ratio (TTM) 3.29





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com